Jana Stojanova
Overview
Explore the profile of Jana Stojanova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stojanova J, Helsby N, Wright D, Murnion B, Day R
Br J Clin Pharmacol
. 2025 Feb;
PMID: 40000440
No abstract available.
2.
Sofi-Mahmudi A, Stojanova J, Vounzoulaki E, Tomlinson E, Pizarro A, Khademioore S, et al.
J Clin Epidemiol
. 2025 Feb;
181:111719.
PMID: 39947447
Objectives: The aim of this study was to examine the distribution of country, region, language, and gender diversity in the authorship of Cochrane reviews and compare it to non-Cochrane systematic...
3.
Olivetti C, Fernandez M, Stojanova J, Ruvinsky S, Mangano A, Schaiquevich P
Methods Protoc
. 2024 Aug;
7(4).
PMID: 39195442
3-indoxyl sulfate (3-IS) results from a hepatic transformation of indole, a tryptophan degradation product produced by commensal gut bacteria. The metabolite has shown promise as a biomarker of dysbiosis and...
4.
Shen I, Stojanova J, Yeo M, Olsen N, Lockart I, Wang M, et al.
Br J Clin Pharmacol
. 2024 Jun;
90(10):2529-2538.
PMID: 38881155
Aims: Advanced chronic liver disease and advanced chronic liver disease-related ascites have a high mortality. The pharmacological treatment of ascites and fluid overload has changed little over time. Empagliflozin, a...
5.
Stojanova J, Brown J, Reuter S, Marriott D
Int J Antimicrob Agents
. 2024 Apr;
63(6):107170.
PMID: 38604388
No abstract available.
6.
Carland J, Stojanova J, Lau C, Day R, Marriott D
Ther Drug Monit
. 2024 Feb;
46(3):415-416.
PMID: 38321597
No abstract available.
7.
Carrasco-Wong I, Gonzalez-Ortiz M, Araujo G, Lima V, Giachini F, Stojanova J, et al.
Adv Exp Med Biol
. 2023 Jul;
1428:287-307.
PMID: 37466779
Currently, more than 100,000 papers had been published studying the placenta in both physiological and pathological contexts. However, relevant health conditions affecting placental function, mostly found in low-income countries, should...
8.
Robosa R, Lau C, Stojanova J, Chin C, Marriott D
Ther Drug Monit
. 2023 Jul;
45(6):711-713.
PMID: 37448154
Ceftazidime-avibactam (CTZ-AVM) is a novel cephalosporin/beta-lactamase inhibitor with broad-spectrum activity against multidrug-resistant Pseudomonas aeruginosa . Ceftazidime-induced neurotoxicity is a well-described adverse effect, particularly in patients with renal insufficiency. However, appropriate...
9.
Burrows F, Carlos L, Stojanova J, Marriott D
Int J Antimicrob Agents
. 2023 Jun;
62(3):106908.
PMID: 37385563
Aim: Tacrolimus is a CYP3A4 substrate with a narrow therapeutic index that requires dose adjustment when used with voriconazole, a recognized CYP3A4 inhibitor. Interactions involving flucloxacillin and tacrolimus or voriconazole...
10.
Mandiola M, Arancibia M, Elton V, Madrid E, Meza N, Stojanova J, et al.
Rev Med Chil
. 2023 Jun;
150(8):1046-1053.
PMID: 37358152
Background: Both perfectionism and social anxiety have been described in patients with eating disorders (ED) and medical students. Academic stress also can increase the risk of developing ED. Aim: To...